Leinamycin, DC107

Details of activity:	Potent anti-tumour antibiotic
Institute where first reported:	Tokyo Res. Labs and Pharm Labs
Year first mentioned:	1990
Development status:	Inactive

Chemical structure(s):
Canonical SMILES:	C/C/1=C\[C@H](C(=O)/C=C/C=C\C2=CSC(=N2)[C@@H](C)NC(=O)C[C@]3(CC1)[C@](C)(C(=O)SS3=O)O)O
Isomeric SMILES:	C[C@@H]1C2=NC(=CS2)/C=C\C=C\C(=O)[C@@H](/C=C(/CC[C@@]3(CC(=O)N1)[C@@](C(=O)SS3=O)(C)O)\C)O
InChI:	InChI=1S/C22H26N2O6S3/c1-13-8-9-22(21(3,29)20(28)32-33(22)30)11-18(27)23-14(2)19-24-15(12-31-19)6-4-5-7-16(25)17(26)10-13/h4-7,10,12,14,17,26,29H,8-9,11H2,1-3H3,(H,23,27)/b6-4-,7-5+,13-10+/t14-,17-,21+,22-,33?/m1/s1
InChI Key:	ZHTRILQJTPJGNK-FYBAATNNSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/9849230

External links:
Guide to Pharmacology:	leinamycin